✦ LIBER ✦

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

✍ Scribed by Ligia Traldi Macedo, Andre Bacellar da Costa Lima, Andre Deeke Sasse

Book ID: 119897631
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 439 KB
Volume: 12
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-89

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation between tumour response to firs

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

✍ Marc Buyse; Pierre Thirion; Robert W Carlson; Tomasz Burzykowski; Geert Molenber 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 123 KB

Optimal duration of first-line chemother

Optimal duration of first-line chemotherapy for advanced non-small cell lung cancer: A systematic review with meta-analysis

✍ João Paulo da Silveira Nogueira Lima; Lucas Vieira dos Santos; Emma Chen Sasse; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 410 KB

FOLFIRI-Bevacizumab As First-Line Chemot

FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials

✍ Petrelli, Fausto; Borgonovo, Karen; Cabiddu, Mary; Ghilardi, Mara; Lonati, Veron 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 904 KB

9005 ORAL Is There a Benefit to Maintena

9005 ORAL Is There a Benefit to Maintenance Therapy After First Line Chemotherapy in Advanced Non-small Cell Lung Cancer – a Systematic Review With Meta-analysis

✍ DesGuetz, G.; Uzzan, B.; Chouahnia, K.; Nicolas, P.; Perol, M.; Morere, J.F. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB

6051 Balancing pros and cons of the addi

6051 Balancing pros and cons of the addition of Bevacizumab (BEVA) to first-line chemotherapy (CT) for advanced/metastatic colorectal cancer (MCRC): Meta-analysis of randomized clinical trials exploring absolute benefits

✍ Cuppone, F.; Vaccaro, V.; Loupakis, F.; Milella, M.; Carlini, P.; Nisticò, C.; F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Predictive Value of XRCC1 Gene Polymorph

Predictive Value of XRCC1 Gene Polymorphisms on Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients: A Systematic Review and Meta-analysis

✍ Wu, J.; Liu, J.; Zhou, Y.; Ying, J.; Zou, H.; Guo, S.; Wang, L.; Zhao, N.; Hu, J 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 423 KB